Trial: 202007122

Blood acquisition for circulating tumor DNA (ctDNA) analysis for patients undergoing peptide receptor radionuclide therapy (PRRT) in patients with metastatic unresectable gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Phase

N/A

Principal Investigator

Trikalinos, Nikolaos

Disease Site

Metastatic Disease; Other Digestive Organ; Other Endocrine System; Pancreas